IP Library Patent Application 12157989
Patent Application
App. No. 12/157,989

Combination treatment modification methods and systems

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/157,989
Abstract

Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or modifying an artificial sensory experience to alter at least one effect of the bioactive agent.

Claims (58)

1 - 64 . (canceled)

65 . A system, comprising:

an acceptor module;

a modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent.

66 . The system of claim 65 , wherein the acceptor module comprises:

an acceptor module configured for accepting an identification of at least one medication prescribed for an individual.

67 . The system of claim 66 , wherein the acceptor module configured for accepting an identification of at least one medication prescribed for an individual comprises:

an acceptor module configured for accepting an identification of at least one of an anti-depressant, an anxiolytic medication, a pain medication, a behavior modifying medication, a weight-loss drug, an anti-Alzheimer's medication, or an anti-stroke medication as the at least one medication.

68 . The system of claim 65 , wherein the acceptor module comprises:

an acceptor module configured for accepting an identification of an illicit substance used by an individual.

69 . The system of claim 68 , wherein the acceptor module configured for accepting an identification of an illicit substance used by an individual comprises:

an acceptor module configured for accepting an identification of at least one of alcohol use, psychoactive drug use, tranquilizer use, methamphetamine use, or narcotic use.

70 . The system of claim 65 , wherein the acceptor module comprises:

an acceptor module configured for accepting an identification of a nutraceutical used by an individual.

71 . The system of claim 70 , wherein the acceptor module configured for accepting an identification of a nutraceutical used by an individual comprises:

an acceptor module configured for accepting an identification of at least one of a memory supplement, an anti-oxidant, a cancer preventative, or a mood-changing agent.

72 . The system of claim 65 , wherein the acceptor module comprises:

an acceptor module configured for accepting at least one indication of bioactive agent use by at least one of a computer game participant, a social networking website participant, a virtual world participant, an online student, an online medical information user, or an on-line shopper.

73 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying access to at least a portion of the artificial sensory experience to alter at least one effect of the bioactive agent.

74 . The system of claim 73 , wherein the modifier module configured for modifying access to at least a portion of the artificial sensory experience to alter at least one effect of the bioactive agent comprises:

a restrictor module configured for restricting access to at least a portion of the artificial sensory experience.

75 . The system of claim 73 , wherein the modifier module configured for modifying access to at least a portion of the artificial sensory experience to alter at least one effect of the bioactive agent comprises:

a granter module configured for granting access to at least a portion of the artificial sensory experience.

76 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying a visual object in an artificial sensory experience to alter at least one effect of the bioactive agent.

77 . The system of claim 76 , wherein the modifier module configured for modifying a visual object in an artificial sensory experience to alter at least one effect of the bioactive agent comprises:

a modifier module configured for modifying a color scheme of an artificial sensory experience to alter at least one effect of the bioactive agent.

78 . The system of claim 76 , wherein the modifier module configured for modifying a visual object in an artificial sensory experience to alter at least one effect of the bioactive agent comprises:

a modifier module configured for modifying at least a portion of text of an artificial sensory experience to alter at least one effect of the bioactive agent.

79 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

an alterer module configured for altering a sound in the artificial sensory experience.

80 . The system of claim 79 , wherein the alterer module configured for altering a sound in the artificial sensory experience comprises:

an alterer module configured for altering at least a portion of music in the artificial sensory experience.

81 . The system of claim 79 , wherein the alterer module configured for altering a sound in the artificial sensory experience comprises:

an alterer module configured for altering at least a portion of ambient noise in the artificial sensory experience.

82 . The system of claim 79 , wherein the alterer module configured for altering a sound in the artificial sensory experience comprises:

an alterer module configured for altering at least a portion of voice in the artificial sensory experience.

83 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying an artificial sensory experience to enhance efficacy of the bioactive agent.

84 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying an artificial sensory experience to reduce a side effect of the bioactive agent.

85 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

an adder module configured for adding at least one of visual or audio content to the artificial sensory experience.

86 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a deleter module configured for deleting at least one of visual or audio content of the artificial sensory experience.

87 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

an adder module configured for adding content to the artificial sensory experience and deleting different content of the artificial sensory experience.

88 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying a sensate experience to alter at least one effect of the bioactive agent.

89 . The system of claim 88 , wherein the modifier module configured for modifying a sensate experience to alter at least one effect of the bioactive agent comprises:

a modifier module configured for modifying at least one of an olfactory stimulus, a haptic stimulus, a visual stimulus, an auditory stimulus, or a taste stimulus to alter at least one effect of the bioactive agent.

90 . The system of claim 65 , wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying an artificial sensory experience implemented on a mobile device.

91 . The system of claim 65 , wherein the acceptor module and the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprise:

an acceptor module configured for accepting an identification of at least one of a pain medication, an antianxiety medication, an anti-addiction medication, an eating disorder medication, an anti-obesity medication, or a mood-altering medication prescribed for an individual and modifying an artificial sensory experience to alter at least one effect of the bioactive agent.

92 . The system of claim 65 , wherein the acceptor module and the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprise:

an acceptor module configured for accepting an identification of at least one anti-depressant medication prescribed for an individual and adding at least one cheerful attribute to a virtual world experience to enhance an anti-depressive effect of the anti-depressant medication.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2013
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I LLC
Reel/Frame 031442/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2008
From: HYDE, RODERICK A.; ISHIKAWA, MURIEL Y.; LEUTHARDT, ERIC C.; LEVIEN, ROYCE A.; LORD, ROBERT W.; MALAMUD, MARK A.; SWEENEY, ELIZABETH A.; WOOD, JR., LOWELL L.; WOOD, VICTORIA Y.H.
To: SEARETE LLC
Reel/Frame 021611/0649 →